Barclays upgraded Align Technology (ALGN) to Overweight from Equal Weight with an unchanged price target of $200. The stock’s risk/reward is improved with the Middle East conflict driving a 15% pullback from Align’s February high, the analyst tells investors in a research note. Barclays, which admits its call could prove premature if the conflict drags on, believes Align is well positioned to benefit post-conflict.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Tech Updates Bylaws to Enable Shareholder Meetings
- Align Technology price target raised to $200 from $170 at Barclays
- Align Technology upgraded to Buy from Hold at HSBC
- Leerink upgrades Envista to Outperform on improved growth, execution
- Align Technology Earnings Call: Record Sales, Tight Margins